New recall affects certain LEADER brand eye drops; FDA says it found unsanitary conditions in facility where they are manufactured
THURSDAY, Nov. 2, 2023 (HealthDay News) — Cardinal Health is voluntarily recalling certain LEADER brand eye drops because they may cause eye infections.
The U.S. Food and Drug Administration informed the Dublin, Ohio, company that agency investigators found unsanitary conditions in its manufacturing facility. Tests of critical drug production areas of the facility were positive for bacteria. The drops were supplied by Velocity Pharma.
Cardinal Health has received reports of three adverse events related to these products and have shared this information with its supplier, the recall notice said.
These eye drops are sold over the counter for temporary relief of burning and irritation due to dryness, to protect against further irritation, and to relieve redness. They were sent to wholesalers and retailers starting in December 2021.
While the company is notifying its direct accounts via mail and arranging for return of the products, wholesalers, distributors, and retailers should stop selling the eye drops.
Consumers should also stop using them. They may return any of the recalled products to the place they bought them.
Atropine Eye Drops Reduce Myopia Progression in Children 
Inclined Sleeper-Associated Sudden Unexpected Infant Deaths Continued After Recall 
Preservative-Free Artificial Tears Aid Eye Symptoms in Digital Device Users 
Bausch + Lomb Issues Recall of enVista Lenses Used in Cataract Surgery 
Full, Limited Functional Endoscopic Sinus Surgery Beneficial in Rhinosinusitis With Nasal Polyps 
Randomized Trial of Early Vitrectomy Feasible for Postoperative Endophthalmitis 
Seniors Undergoing High-Risk Emergency General Surgery Have Fewer Healthy Days at Home 
Lung Transplant Can Prolong Survival in Stage IV NSCLC 
